FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/065429 [Registered on: 08/04/2024] Trial Registered Prospectively
Last Modified On: 03/04/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Other 
Public Title of Study   An easy way to understand training and exercises before the operation for low back pain to reduce pain and fear to move after the operation 
Scientific Title of Study   Efficacy Of Culturally Sensitive Prehabilitation In Improving Post Operative Pain And Fear Of Movement In Individuals With Lumbar Degenerative Disc Disease – An Experimental Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Harsha Wadhwani 
Designation  clinical therapist 
Affiliation  MGM School of Physiotherapy 
Address  Department of Musculoskeletal Physiotherapy, Mahatma Gandhi Mission School of Physiotherapy N-6 CIDCO, Chhatrapati Sambhajinagar-431003, A Constituent unit of MGMIHS, Navi Mumbai
Department of Musculoskeletal Physiotherapy, Mahatma Gandhi Mission School of Physiotherapy N-6 CIDCO, Chhatrapati Sambhajinagar-431003, A Constituent unit of MGMIHS, Navi Mumbai
Aurangabad
MAHARASHTRA
431003
India 
Phone  9404880712  
Fax    
Email  harsha14wadhwani@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vaibhavi Walimbe 
Designation  Assistant Professor 
Affiliation  MGM School of Physiotherapy 
Address  MGM School of Physiotherapy N-6 CIDCO, Aurangabad-431003

Aurangabad
MAHARASHTRA
431003
India 
Phone    
Fax    
Email  vaibhavi.walimbe@mgmsop.edu.in  
 
Details of Contact Person
Public Query
 
Name  Harsha Wadhwani 
Designation  clinical therapist 
Affiliation  MGM School of Physiotherapy 
Address  Department of Musculoskeletal Physiotherapy, Mahatma Gandhi Mission School of Physiotherapy N-6 CIDCO, Chhatrapati Sambhajinagar-431003, A Constituent unit of MGMIHS, Navi Mumbai
Department of Musculoskeletal Physiotherapy, Mahatma Gandhi Mission School of Physiotherapy N-6 CIDCO, Chhatrapati Sambhajinagar-431003, A Constituent unit of MGMIHS, Navi Mumbai
Aurangabad
MAHARASHTRA
431003
India 
Phone  9404880712  
Fax    
Email  harsha14wadhwani@gmail.com  
 
Source of Monetary or Material Support  
MGM Medical College and Hospital Chh Sambhajinagar 
 
Primary Sponsor  
Name  Harsha Wadhwani 
Address  MGM School of Physiotherapy N-6 CIDCO, Aurangabad-431003  
Type of Sponsor  Other [personal] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Harsha Wadhwani  MGM Medical College and Hospital  Department of Musculoskeletal Physiotherapy, Mahatma Gandhi Mission School of Physiotherapy N-6 CIDCO, Chhatrapati Sambhajinagar-431003, A Constituent unit of MGMIHS, Navi Mumbai
Aurangabad
MAHARASHTRA 
9404880712

harsha14wadhwani@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
MGM-ECRHS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  , (1) ICD-10 Condition: M959||Acquired deformity of musculoskeletal system, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Culturally sensitive Pre-habilitation  10 sessions of Pre-habilitation (BD) along with 5 sessions of culturally sensitive patient education 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1)Patients undergoing surgery for degenerative disc disease
2)NPRS criteria- 5 or more
3)Kinesiophobia (TAMPA scale)- score of 37 or more
4)Both male and female patients 
 
ExclusionCriteria 
Details  1) Patient with non surgical condition.
2)Patients with previous surgical history.
3)Patients with other musculoskeletal conditions.
4)Patients with prior back surgery, and spinal infections.
5)Other metabolic diseases, pregnancy and malignancy.
6)Abdominal pathologies and renal calculi. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Pain (NPRS)  one week (7 days) 
 
Secondary Outcome  
Outcome  TimePoints 
Fear of movement (TAMPA scale of kinesiophobia)  pre-outcome measure day 1 and post outcome measure day 7 
 
Target Sample Size   Total Sample Size="41"
Sample Size from India="41" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response (Others) -  scientific journals

  6. For how long will this data be available start date provided 16-09-2024 and end date provided 16-09-2025?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   Recriutment has not yet been started. Recruitment will start after the study is registered at CTRI.     
Close